Clinical trial
Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
NCT04056182 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- January 29, 2021
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid-use disorder